Copy
View this email in your browser
Share Share
Tweet Tweet
Forward Forward

Update for Primary Care

Our latest primary care news and guidance.
 
June 2022
COVID-19News | Clinical knowledge summaries | Events | Blogs | Get involved | Other resources | Announcements

COVID-19

Updates to managing COVID-19 guideline


We've:
Read managing COVID-19 update information
We are continuously updating our COVID-19 guidelines to incorporate the latest evidence and keep abreast of new developments in diagnosing and treating COVID-19. We’ll highlight recent updates in this monthly email communication, or you can keep up to date on the latest live changes through our website.

News

Triglycerides test viala triglycerides test vial

New treatment to prevent heart attacks and strokes in people with raised triglycerides

We've recommended icosapent ethyl for reducing the risk of cardiovascular events in adults with raised triglycerides. 425,000 people with controlled low-density lipoprotein cholesterol who are taking a statin and have raised levels of triglycerides could benefit from this treatment. Until now, there have been no medicines for people at risk of cardiovascular events who have raised levels of triglycerides despite having statins with or without ezetimibe (another type of anti-cholesterol medicine).

Social worked helping a mature person with complex needs use a laptop

Social work with adults experiencing complex needs

People with lived and work experience of social work have developed new evidence-based guidance on this topic. The guideline covers planning, delivery and review of interventions, how inequalities can be reduced and support for social workers in multidisciplinary teams. As well as social care staff, it’s also relevant for healthcare staff and allied health professionals who support people with complex needs. 

Catch up on all our latest news articles
NICE Talks logo

New social work guideline to help support adults experiencing complex needs

In this month’s NICE Talks podcast, we discuss the positive impact our new guidance will have on people using social work services. Joining the discussion are members of the guideline committee that developed our recommendations.

Listen to our complex needs podcast

Clinical knowledge summaries

New topics and updates include:

  • Contraception - combined hormonal methods. Angioedema was added as an adverse effect in line with revised manufacturer's supplementary protection certificates.
  • Diabetes - type 2. Adverse effects and contraindications of metformin and SGLT-2 inhibitors were updated in line with revised manufacturer's supplementary protection certificates.
  • Epilepsy. Topic was updated to align with our guideline on epilepsies in children, young people and adults.
  • Gastro-oesophageal reflux disease in children. Due to the global withdrawal of ranitidine, its recommendation was changed to H2 receptor antagonists. Omeprazole dosing was revised to include an update from the BNF and to remove the advice that this is a special preparation, as there are oral suspensions available on prescription.
  • Cluster headache. Detailed information about sumatriptan and zolmitriptan preparations for acute treatment of cluster headache was added.
  • Irritable bowel syndrome. Diagnosis and management recommendations were updated in line with guidance from the NICE and the British Society of Gastroenterology.
Our CKS provide primary care practitioners with a readily accessible summary of the evidence base and best practice guidance for over 370 topics. These cover over 1,000 clinical presentations or patient scenarios, free to access in the UK.
Browse CKS library

Events

Early value assessment for medical technologies event

Join us to hear about our new approach to providing early value assessment for medical technologies: 

  • Driving innovation into the hands of health and care professionals, Monday 18 July 2022, 11am to 12noon, online.

Through early value assessment, we'll offer rapid assessments of the most promising and impactful digital products, devices and diagnostics where the evidence base is still emerging. We will produce these assessments more quickly than our existing medical technologies guidance. We will also provide expert judgement about what further real world evidence needs to be collected when the product is introduced to the NHS, for a full evaluation later.

This month, we'll begin assessment of our first 2 pilot topics - digital apps for depression and anxiety in children. We aim to publish these in October. Other topics will follow in adult mental health, early cancer diagnosis and cardiovascular disease.  

Register for early value assessment event
For more information about early value assessment, read our blog post, 'NICE's early value assessment for medtech: panning for nuggets of innovation gold'.

Blogs

Jenniffer Prescott, NICE's programme director of health technology appraisals process and operations.

Increasing the capacity of our technology appraisals - the proportionate way

We are trialling a new, proportionate approach to technology appraisals. We expect that this will increase our capacity by 20% from 2023/24. You can read more about the approach and its potential impact in this blog from Jenniffer Prescott, NICE's programme director of health technology appraisals process and operations.

Read Jennifer's blog

Get involved

Comment on a consultation

Our current consultations include:

Consultation is a key part of our guidance development process. It enables those with an interest in our guidance to comment at specific stages and feedback into the decision-making process.
See all our open consultations

Join a committee

We’re looking for primary care professionals, including a pharmacist with experience in pharmacogenomics and a GP, to join our:

Our guidance and quality standards are developed by independent committees. Join us and have an active role in producing a guideline or quality standard.
See all our committee vacancies

Observe a meeting

Our advisory committee meetings, technology appraisal appeal hearings and public board meetings are open to the public. Holding them in public supports our commitment to having processes in place that are rigorous, open, and transparent. 

We’re currently holding all our public meetings virtually.

See all our public meetings

Other resources

Easy read guides

Our easy read guides provide accessible information for people who have difficulty with reading. We encourage primary care staff to share these guides with the people they care for.

Announcements

Our business plan for 2022 to 2023

We’ve published our business plan for the year ahead. It explains our priorities and outlines 4 key objectives:

  1. Improving the usefulness and usability of our guidelines by developing digital living guideline recommendations for breast cancer, with a new model of support for adoption of best practice. 
  2. Expanding our capacity by 20% through developing a more proportionate approach to our technology appraisal guidance for medicines.
  3. Actively drawing in medical devices, diagnostics and digital products that address national unmet needs and providing quicker assessments of early value to identify the most promising technologies conditional on further evidence generation.
  4. Transformation of the way we work, including our technology, processes and behaviours.
Read our business plan
World EBHC Day 2022 banner

Join the World Evidence-Based Healthcare (EBHC) Day 2022 campaign

World EBHC Day takes place on Friday 20 October. This year, the campaign focuses on partnerships for purpose and how partnerships can bridge research, policy and practice to realise the potential of evidence-based healthcare.

As an official partner, we're encouraging you to take part. Get involved by becoming an evidence ambassador or by sharing your experience about partnerships in evidence-based healthcare through a blog or short video.

Get involved with World EBHC Day 2022
Instagram
Instagram
Facebook
Facebook
Twitter
Twitter
SoundCloud
SoundCloud
YouTube
YouTube
LinkedIn
LinkedIn

unsubscribe from this list